Journal article Published 2017

Isocitrate Dehydrogenase Mutations are Better Prognostic Marker than O6-methylguanine-DNA Methyltransferase Promoter Methylation in Glioblastomas - a Retrospective, Single-centre Molecular Genetics Study of Gliomas

Magdalena Houdová Megová, Jiří Drábek, Z. Dwight, Radek Trojanec, Vladimíra Koudeláková, Jana Vrbková, Ondřej Kalita, Soňa Mlčochová, Miroslava Rabčanová, Marián Hajdúch

Klinická onkologie 30(5), 361-371 (2017)

Cite

2017 Year

Cite this publication

HOUDOVÁ MEGOVÁ, M., J. DRÁBEK, Z. DWIGHT, R. TROJANEC, V. KOUDELÁKOVÁ, J. VRBKOVÁ, O. KALITA, S. MLČOCHOVÁ, M. RABČANOVÁ, M. HAJDÚCH: Isocitrate Dehydrogenase Mutations are Better Prognostic Marker than O6-methylguanine-DNA Methyltransferase Promoter Methylation in Glioblastomas - a Retrospective, Single-centre Molecular Genetics Study of Gliomas. Klinická onkologie. 2017, 30(5), 361-371, ISSN: 0862-495X.

Isocitrate Dehydrogenase Mutations are Better Prognostic Marker than O6-methylguanine-DNA Methyltransferase Promoter Methylation in Glioblastomas - a Retrospective, Single-centre Molecular Genetics Study of Gliomas

Cite this publication

Details

Authors from EATRIS